Literature DB >> 7823923

The X protein of hepatitis B virus coactivates potent activation domains.

I Haviv1, D Vaizel, Y Shaul.   

Abstract

Transactivation by hepatitis B virus X protein (pX) is promiscuous, but it requires cellular activators. To study the mode of action of pX, we coexpressed pX with Gal4-derived activators in a cotransfection system. Twelve different activators bearing different types of activation domains were compared for their response to pX. Because pX indirectly increases the amount of the activators, tools were developed to compare samples with equivalent amount of activators. We demonstrate that pX preferentially coactivates potent activators, especially those with acidic activation domains. Weak activators with nonacidic activation domains are not potentiated by pX. Interestingly, Gal4E1a, which is not rich in acidic residues but interacts with similar molecular targets, also responds to pX. The response to pX correlated with the strength of the activation domain. Collectively, these data imply that pX is a coactivator, which offers a molecular basis for the pleiotropic effects of pX on transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7823923      PMCID: PMC232011          DOI: 10.1128/MCB.15.2.1079

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  87 in total

1.  Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun.

Authors:  V R Baichwal; R Tjian
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

Review 2.  Commitment and activation at pol II promoters: a tail of protein-protein interactions.

Authors:  B Lewin
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Mechanism of transcriptional activation by Sp1: evidence for coactivators.

Authors:  B F Pugh; R Tjian
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 4.  Activators and targets.

Authors:  M Ptashne; A A Gann
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

5.  Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets.

Authors:  K J Martin; J W Lillie; M R Green
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

6.  Recombinant yeast TFIID, a general transcription factor, mediates activation by the gene-specific factor USF in a chromatin assembly assay.

Authors:  M Meisterernst; M Horikoshi; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Trans-activation of HLA-DR gene by hepatitis B virus X gene product.

Authors:  K Q Hu; J M Vierling; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Activation of class I major histocompatibility complex gene expression by hepatitis B virus.

Authors:  D X Zhou; A Taraboulos; J H Ou; T S Yen
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription.

Authors:  H F Yang-Yen; R Chiu; M Karin
Journal:  New Biol       Date:  1990-04

10.  X protein of hepatitis B virus resembles a serine protease inhibitor.

Authors:  S Takada; K Koike
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  30 in total

1.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

2.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.

Authors:  E Veal; M Eisenstein; Z H Tseng; G Gill
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.

Authors:  I Haviv; Y Matza; Y Shaul
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

5.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

6.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

7.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors.

Authors:  M O Imhof; D P McDonnell
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  ADA5/SPT20 links the ADA and SPT genes, which are involved in yeast transcription.

Authors:  G A Marcus; J Horiuchi; N Silverman; L Guarente
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis.

Authors:  Zhaorui Lian; Jie Liu; Li Li; Xianxing Li; N Lale Satiroglu Tufan; Marcy Clayton; Meng-Chao Wu; Hong-Yang Wang; Patrick Arbuthnot; Michael Kew; Mark A Feitelson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.